**Clinical Aspects**

[73] Hodi, F.S., et al., Improved survival with ipilimumab in patients with metastatic mel‐

[74] Azad, A.K., et al., Validation of genetic sequence variants as prognostic factors in ear‐ ly-stage head and neck squamous cell cancer survival. Clin Cancer Res, 2012. 18(1): p.

[75] Kammerer, P.W., et al., Association of T-cell regulatory gene polymorphisms with or‐

[76] Malaspina, T.S., et al., Enhanced programmed death 1 (PD-1) and PD-1 ligand (PD-L1) expression in patients with actinic cheilitis and oral squamous cell carcinoma.

[77] Tsushima, F., et al., Predominant expression of B7-H1 and its immunoregulatory

roles in oral squamous cell carcinoma. Oral Oncol, 2006. 42(3): p. 268-74.

al squamous cell carcinoma. Oral Oncol, 2010. 46(7): p. 543-8.

Cancer Immunol Immunother, 2011. 60(7): p. 965-74.

anoma. N Engl J Med, 2010. 363(8): p. 711-23.

72 Contemporary Issues in Head and Neck Cancer Management

196-206.
